Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Dividend Yield Fund median (11 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 16 Sep 2024 – 20 Aug 2026, limited by Baroda BNP Paribas Dividend Yield Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Baroda BNP Paribas Dividend Yield Fund | Nifty 500 |
|---|---|---|
| 16 Sep 2024 | ₹100.00 | ₹100.00 |
| 14 Nov 2024 | ₹91.17 | ₹91.63 |
| 11 Jan 2025 | ₹90.68 | ₹90.95 |
| 11 Mar 2025 | ₹84.88 | ₹84.71 |
| 08 May 2025 | ₹89.80 | ₹91.13 |
| 06 Jul 2025 | ₹96.54 | ₹98.31 |
| 03 Sep 2025 | ₹93.05 | ₹95.40 |
| 31 Oct 2025 | ₹96.55 | ₹98.92 |
| 29 Dec 2025 | ₹97.25 | ₹98.81 |
| 25 Feb 2026 | ₹97.45 | ₹97.65 |
| 25 Apr 2026 | ₹92.84 | ₹94.17 |
| 22 Jun 2026 | ₹95.29 | ₹97.05 |
| 20 Aug 2026 | ₹97.98 | ₹98.10 |
| Metric | Baroda BNP Paribas · Regular NAV ₹9.87 Very High risk ★★★☆☆ 1Y | Category median Dividend Yield Fund · 11 funds |
|---|---|---|
| +3.86% | +2.53% | |
| — | +14.45% | |
| — | +14.04% | |
| — | +13.75% | |
| -1.05% | +13.85% | |
| +4.49% | — | |
| — | +15.33% | |
| — | +14.16% | |
| — | +13.21% | |
| Risk | ||
| 12.70% | 13.31% | |
| -0.21 | 0.51 | |
| -0.28 | 0.69 | |
| -18.73% | -20.93% | |
| Nifty 500 | — | |
| — | +2.30% | |
| — | 0.92 | |
| — | 102.1% | |
| — | 89.8% | |
| 2.52% | 2.29% | |
| ₹628.93Cr | ₹1,457Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹250 | — | |
| ₹1.00K | — | |
| 47% | 8% | |
| Himanshu Singh | — | |
| 16 Sep 2024 | — | |
| 42 | — | |
| 41.0% | — | |
| -1.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.